Prostock-studio | Shutterstock

Share:

Koprince Law – In an effort to combat the spread of COVID-19, Congress is seeking to eliminate some red tape surrounding biomedical research and development. Specifically, Congress has removed approval requirements on specific transitions to support advanced research and development initiatives.

Read the full post at SmallGovCon

Share: